Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 1, 2024
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
Patrick Trucchio Maintained (ALT) at Strong Buy with Decreased Target to $12 on, Apr 1st, 2024
Patrick Trucchio of HC Wainwright & Co., Maintained "Altimmune, Inc." (ALT) at Strong Buy with Decreased Target from $15 to $12 on, Apr 1st, 2024.
Patrick has made no other calls on ALT in the last 4 months.
There are 2 other peers that have a rating on ALT. Out of the 2 peers that are also analyzing ALT, 1 agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Corinne Jenkins of "Goldman Sachs" Initiated at Hold and Held Target at $13 on, Wednesday, January 24th, 2024
This is the rating of the analyst that currently disagrees with Patrick
- Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $20 on, Thursday, March 28th, 2024
